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Addition reactions of acid chlorides with various 2-substituted 4,5-dihydro-4,4-
dimethyl-5-methylthio-1,3-thiazoles under basic conditions were studied. Two kinds 
of products were obtained from these addition reactions, β-lactams and non-β-lactam 
adducts. When the reaction was carried out with 4,5-dihydro-1,3-thiazoles with a 
phenyl substituent at C(2), the reaction proceeded via formal [2+2] cycloaddition and 
led to the correspoding β-lactam. On the other hand, acid chlorides and 4,5-dihydro-
1,3-thiazoles bearing an α-H-atom at the C(2)-substituent underwent C(α)- and/or N-
addition reactions and gave rise to non-β-lactam adducts, i.e. C(α)- and/or N-acylated 
1,3-thiazolidines. The attempted transformations of sulfonyl esters of exo-6-
hydroxypenams to endo-6-azidopenams failed, although they were successful with 
mono-β-lactams under the same conditions. 
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1. Introduction. – A convenient synthesis of 4,4-disubstituted 1,3-thiazole-
5(4H)-thiones 1, the less well-known di-sulfur analogs of 1,3-oxazol-5(4H)-ones 
(azlactones), was developed in the eighties [2]. The method also allowed the 
preparation of enantiomerically pure examples [3]. In a large series of experiments, it 
has been shown that the C=S group of 1 is the most reactive part of the molecule [4]. 
Therefore, derivatives 1 have been used as models for 1,3-dipolaar cycloadditions [5], 
hetero-Diels-Alder reactions [6], and [2+2] cycloadditions [7] with C=S compounds, 
as well as for the study of BF3-catalyzed reactions with oxiranes [8] and thiophilic 
versus carbophilic additions of organometal compounds [9]. 
After transformation of the C=S group of 1a (R1 = Ph, R2 = R3 = Me) into the 
methylsulfanyl derivative 2a (R2 = R3 = Me), treatment of the latter with one mole-
equiv. of dichloroacetyl chloride (3a) followed by Et3N led to a 2:1 mixture of the β-
lactam derivative 4a (a ‘penam’) and the 2-methylen-1,3-oxazin-6-one 53) in a total 
yield of 44% [10] (Scheme 1). Under analogous reaction condtitions, cis-2b  (R2 = Me, 
R3 = i-Pr) gave a single product 4b with all-cis-configuration (all substituents MeS, i-
Pr, and Ph in exo positions) in 94% yield. The reaction of 2a with azidoacetyl chloride 
yielded the penam of type 4 with exo-orientation of the azido group at C(6) [10]. 
 
Scheme 1 
 
                                                 
3) The structure of 5 was established by X-ray crystallography (H. Heimgartner, J. H. 
Bieri, R. Prewo, A. Linden, C. Jenny, Private Communication CCDC, Cambridge, 
England, 1993. CSD refcode: HACPUW). 
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β-Lactam antibiotics belong to the most efficient agents in fighting bacterial 
infections4). Mostly, the β-lactam antibiotics are the products of fermentation and 
semi-synthesis, and despite many efforts, only a couple of monocyclic β-lactams are 
produced by total synthesis. Nevertheless, there is a continuing interest in new 
synthetic methods towards this highly desired class of compounds (see, e.g., [12]). 
Among the various methods for the preparation of β-lactams, the acid chloride/imine 
(ketene/imine) addition is one of the most widely used. Since its discovery by 
Staudinger in 1907 [13], the scope and limitations of this method have been studied 
extensively, and much progress has been made on the synthesis of monocyclic β-
lactams [14]. However, for the synthesis of bicyclic β-lactams, e.g., penams, this 
method suffers in two ways: the poor yield of the reaction and the low or inappropriate 
stereoselectivity. Although the problem of the wrong configuration at C(6) has been 
solved by the transformation of 6-epipenicillin to penicillin [15], the epimerization is a 
multistep process and gives the product only in low yield. Therefore, a number of 
studies concerning the formation of the penam skeleton via the reaction of 4,5-
dihydro-1,3-thiazoles with various acetylchlorides/base, i.e., the imine/ketene addition, 
have been published [16]. Furthermore, the continuing interest in penam derivatives is 
shown by the elaboration of new methods for their preparation (e.g. [17]), the 
synthesis of analogs such as selenapenams [18], and the modifcation of known 
compounds, e.g., 6-aminopenicillic acid (6-APA) [19]. 
The aim of the present study was the extension of the reaction 2 → 4 on 4,5-
dihydro-1,3-thiazoles of type 2 with a PhCH2 or a Me group at C(2), as well as on 
acetyl chlorides bearing an acetoxy or phthalimido group. Furthermore, a method for 
                                                 
4) For recent reviews, see [11]. 
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transformation of 6-exo-substituted penams into the corresponding 6-endo-azido 
derivatives should be elaborated. 
 
2. Results and Discussion. – 2.1. Reactions of 4,5-Dihydro-1,3-thiazoles 2 
with Acetyl Chlorides and Et3N. The substituted 4,5-dihydro-4,4-dimethyl-5-
methylthio-1,3-thiazoles 2 were synthesized from by treatment of the corresponding 
4,4-dimethyl-1,3-thiazole-5(4H)-thione 1 with MeLi in THF at –78° [9a]. When 2a 
was treated with acetoxyacetyl chloride (3b) in CH2Cl2 at room temperature in the 
presence of Et3N, two products endo-6a and exo-6a were formed in a ratio of ca. 2:1, 
isolated in 62% yield after chromatographic workup. The two stereoisomers were 
separated by prep. TLC. On the basis of the spectroscopic data, the structures of 
isomeric penams 6 were assigned (Scheme 2). As it has been shown that in [2+2] 
cycloadducts of 4,5-dihydro-1,3-thiazoles with ketenes the ring S-atom is 
unmistakably oriented trans to the group with a heteroatom at C(6) [20], endo-6a and 
exo-6a were assigned both as 5,6-trans products. Then, the remaining possibility for 
the presence of isomers must be the result of different configurations of the MeS 
substituent at C(2), as the reaction started from racemic 2a. Hence, endo-6a and exo-
6a were assigned as the diastereoisomers with 2-endo- and 2-exo-5,6-trans-bicyclic 
penams, respectively. Finally, the structure of endo-6a was confirmed by X-ray 
crystallography (Fig. 1). Similarly, the reaction of 2a and phthalimidoacetyl chloride 
3c also gave a mixture of two diastereoisomers endo-6b and exo-6b (3:1) in a low 
yield of 15% (Scheme 2).  
 
Scheme 2  
 
 6 
Fig. 1. ORTEP Plot [21] of the molecular structure of endo-6a (with 30% probability 
ellipsoids; arbitrary numbering of atoms) 
 
Since the space group of endo-6a is centrosymmetric, the compound in the 
crystal is racemic. Whereas the acetoxy group at the β-lactam ring is exo oriented, i.e., 
cis to the Ph group, the methylsulfanyl group at the thiazolidine ring occupies the endo 
position. 
On the other hand, acid chlorides 3a – 3c reacted with the 2-benzyl substituted 
4,5-dihydro-1,3-thiazole 2b under the same conditions (CH2Cl2, r.t.) to give different 
products. The reaction of 2b with excess dichloroacetyl chloride (3a) gave two 
products in almost equal amounts. According to the NMR spectra, the second product 
consists of a 1:1 mixture of diastereoisomers. The MS and the NMR spectra showed 
that they were derived from 1:1 and 1:2 adducts of 2b and 3a by elimination of one 
and two, respectively, equivalents of HCl. The IR spectra excluded the presence of β-
lactam structures, as both products both lack the absorption at ca. 1750 cm–1, i.e., the 
characteristic β-lactam C=O stretching band. In both compounds, an amide/lactam 
group was indicated by IR absorptions at 1700 and 1720/1710 cm–1, respectively, and 
13C-NMR signals at 163.9 and 159.5 ppm, respectively. On the basis of the 
specroscopic data, structures 7a and 8 were proposed for these products (Scheme 3). 
Treatment of 7a with excess 3a and Et3N in boiling hexane led to 8 in 31% yield. 
 
Scheme 3 
 
 The same starting materials 2a and 3a reacted in refluxing hexane in the 
presence of Et3N, and the same product 7a was formed together with a new compound 
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9. Again, lack of absorptions for a corresponding C=O group showed that no β-lactam 
was formed; the C=O signals appeared at 1600 cm–1 and 179.5 ppm. Furthermore, a 
NH signal was detected at 10.92 ppm in the 1H-NMR spectrum. The structure of 9 was 
proved undoubtedly by X-ray crystallography (Fig. 2). 
 
Fig. 2. ORTEP Plots [21] of the molecular structures of a) 9 and b) 7b (with 50% 
probability ellipsoids; arbitrary numbering of atoms) 
 
Similar reactions of 2b with acetoxyacetyl chloride (3b) and phthalimidoacetyl 
chloride (3c), respectively, in refluxing hexane gave a single 1:1 adduct 7b or 7c in 
each case (Scheme 4). Furthermore, 2-methyl-4,5-dihydro-1,3-thiazole 2c reacted with 
3a under similar conditions to give the ‘1:2 adduct’ 10 in low yield. The structures of 
all these products were assigned on the basis of their spectroscopic and analytical data 
and, in the case of 7b, the structure was established by X-ray crystallography (Fig. 2).  
The space groups of 9 and 7b are centrosymmetric, therefore, the compounds 
in the crystals are racemic.  The thiazolidine NH group of 9 forms an intramolecular 
H-bond with the O-atom of the side chain C=O group; graph set motif [22] S(6). In the 
case of 7b, the exocyclic C=C bond is (Z)-configured. 
 
Scheme 4 
 
It should be mentioned that all attempts to synthesize spiropenams by the acid 
chloride/imine cycloaddition failed. Under various conditions, C(4)-spirocyclic 4,5-
dihydro-1,3-thiazoles [9c] reacted neither with 3a nor with 3b in the presence of Et3N. 
In most of the cases, the starting materials were recovered in high yields. Similarly, 
 8 
the bulky 2-(tert-butyl)-4,5-dihydro-4,4-dimethyl-5-(methylthio)-1,3-thiazole [9c] also 
failed to react with 2a,b under similar conditions.  
 
2.2. Synthesis of Monocyclic α-Hydroxy-β-lactams and Attempted 
Transformations to α-Azido-β-lactams. With the aim of elaborating reaction 
conditions for the transformation of penams of type 6 into the corresponding 6-endo-
azido derivatives, monocyclic β-lactams were prepared as model compounds. Thus, N-
benzalaniline (11) in CH2Cl2 in the presence of Et3N was reacted with acid chlorides 
3b and 3c, respectively, at room temperature to give the corresponding monocyclic β-
lactams 12a and 12b in good to excellent yield (Scheme 5)5). In the case of 3c, only 
the trans isomer 12b was obtained, whereas in the case of 3b, a 1:1 mixture of cis- and 
trans-12a was isolated. The cis/trans-configurations were assigned on he basis of the 
coupling constants of H–C(3),H–C(4) in the 1H-NMR spectra [24] (see also [23]). 
 
Scheme 5 
 
In several publications, the transformation of cis- and trans-substituted 3-
hydroxyazetidinones to the corresponding 3-azido derivatives with inverted 
configuration has been described (e.g. [25]). For this reason, our intention was to use 
the mixture of cis/trans-12a as a model for this purpose. Firstly, 12a was hydrolyzed 
by treatment with NaHCO3 in MeOH/H2O at 0° to give cis/trans-3-hydroxy-β-lactams 
13 [23a][23c][25b][26] (Scheme 6). The diastereoisomers trans-13 and cis-13 were 
                                                 
5) For analogous recent studies, see [12b][23]. Selective syntheses of cis-12a under 
similar conditions [23a] or at –78° [23b] were reported, those of cis- and trans-12b 
were described in [23d][23e]. 
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separated successfully by flash-chromatography. Subsequent sulfonylation of the two 
isomers with 4-chlorophenylsulfonyl chloride (cf. [23a][25]) gave the sulfonates trans-
14 and cis-14, respectively, in excellent yields. Treatment of the latter with NaN3 in 
DMF at 50–60° afforded via stereoselective SN2 reaction the 3-azido-β-lactams cis-15 
and trans-15, respectively, with complete conversion of the configurations (Scheme 6). 
 
Scheme 6 
 
The successful exchange of the OH group in monocyclic β-lactams for the 
azido group (see above and [25]) encouraged us to try this method in the case of the 
bicyclic β-lactams 6a. In analogy to the monocyclic β-lactams 12, the 
diastereoisomeric mixture 4, as well as the separated 2-endo- and 2-exo-diastereomers 
endo-6a and exo-6a, were hydrolyzed under mild conditions to give the corresponding 
6-hydroxypenams 16 (Scheme 7). The diastereoisomers endo- and exo-16 formed from 
the mixture of endo- and exo-6a could be separated easily by prep. TLC6). 
The structure of exo-16 was established by X-ray crystallography (Fig. 3). 
Since the space group is centrosymmetric, the compound in the crystal is racemic. The 
substituents MeS, Ph, and OH are all exo-oriented. The OH group forms an 
intermolecular H-bond with the carbonyl O-atom of a neighboring molecule and 
thereby links the molecules into extended chains which run parallel to the [100] 
direction and can be described by a graph set motif [22]. 
 
Scheme 7 
                                                 
6) The hydrolyses of the pure diastereoisomers endo-6a and exo-6a led to pure endo-
16 and exo-16, respectively, in a stereospecific manner. 
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Fig. 3. ORTEP Plot [21] of the molecular structure of exo-16 (with 50% probability 
ellipsoids; arbitrary numbering of atoms) 
 
Sulfonylation of 16 in CH2Cl2/Et3N at 0° with 4-chlorophenyl- and 2,4-
dinitrophenylsulfonyl chlorides gave the corresponding sulfonates 17a and 17b, 
respectively, in high yields. Under the same conditions, the reaction of 16 with 
(trifluoromethyl)sulfonyl chloride was carried out, but the corresponding 
sulfonyloxypenam 17c was obtained in only 27% yield as a crude and unstable 
product. Surprisingly, 4,5-dihydro-4,4-dimethyl-5-methylsulfonyl-2-phenyl-1,3-
thiazole (2a) was formed via a decomposition reaction. 
Substitution of the sulfonate 17a with NaN3 under same conditions as in the 
case of monocyclic β-lactams 14 failed; no substitution product, i.e., a 6-azidopenam, 
was formed, and mainly starting material was recovered. Even reactions with the more 
active substrates 17b and 17c did not result in any desired azido product. Instead, 
some decomposition product 2a was formed. As the unstable triflated bicyclic penam 
17c decomposed already under the conditions of its preparation, triflation and 
substitution with NaN3 were conducted in a one pot reaction under mild conditions 
(0°). However, this also failed to afford the desired azido compound, and again some 
cleavage product 2a was isolated. All further attempts to use the more nucleophilic 
and better soluble azido reagents LiN3 and Bu4NN3 also failed to give an azido penam. 
 
3. Conclusions. – The acid chloride/imine cycloaddition has been studied 
extensively, and three mechanistic pathways have been proposed [27]: 1) direct 
acylation of the imine with the acid chloride leads to the intermediate N-acyliminium 
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chloride A or the chloroalkyl amide B, which reacts with base to give the β-lactam; 2) 
the initial formation of a ketene and subsequent [2+2] cycloaddition with an imine, 
perhaps via the zwitterionic intermediate C, yields the β-lactam; 3) deprotonation of 
the initially formed A leads to C which reacts to give the β-lactam (Scheme 8). 
However, it is not possible to predict the stereochemical course of all of the reported 
reactions with a single mechanisms, and it is likely that more than one mechanism is 
involved7). 
 
Scheme 8 
 
In the acid chloride/imine cycloaddition, especially with cyclic imines, the 
heteroatom at the imine C-atom plays an important role in the determination of the 
relative configuration of the resulting β-lactam. It has been reported that a 4,5-
dihydro-1,3-thiazole gives exclusively the 5,6-trans-configured penam in the reaction 
with N-protected glycyl chloride [20]. This observation was confirmed in the present 
study, in which only the 5,6-trans β-lactams 6a and 6b were formed in the reaction of 
4,5-dihydro-1,3-thiazole 2a with acetoxyacetyl chloride (3b) and phthalimidoacetyl 
chloride (3c), respectively (Scheme 2). 
The substituent at C(α) of the acid chloride also has an influence on the 
configuration of the formed β-lactam. It was found that a relatively bulky acid chloride 
leads to the 3,4-trans-configured β-lactam, while a less sterically hindered acid 
chloride had a minor influence on the configuration of the product. For instance, 3c 
                                                 
7) For some recent relevant articles and recent reviews, see [28][29]. 
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and benzalaniline (11) gave exclusively the β-lactam trans-12b, while 3b, under 
analogous conditions, afforded a 1:1 mixture of cis- and trans-12a (Scheme 5). 
The efficiency of the cycloaddition reaction with cyclic imines depends to a 
great extent on the substituent at the imine C-atom. E.g., the reaction of a 2-
unsubstituted 4,5-dihydro-1,3-thiazole with azidoacetyl chloride gave the correspoding 
penam in a very poor yield [30], while the 2-phenyl-substituted 2a afforded the 
bicyclic β-lactams 6a in much higher yield (see also [10]). However, a sterically bulky 
substituent at C(2) may obstruct the reaction, as the 2-tert-butyl analog of 2a failed to 
react with 3a and with 3b, respectively. For similar reasons, 4,4-spiro-4,5-dihydro-1,3-
thiazoles of type 2a failed to give any β-lactam under analogous reaction conditions.  
When the substituent at C(2) of the 4,5-dihydro-1,3-thiazole 2 bears a C(α) H-
atom, the reaction with acid chlorides/Et3N proceeded via another pathway leading to 
N- and/or C-acylated products. The formation of N-acylated products in reactions with 
acid chlorides/Et3N has previously been reported [31]. They might be formed by the 
nucleophilic attack of the imine N-atom onto the ketene or acid chloride (2b→D, 
Scheme 9), followed by a proton-shift in the zwitterion D to give 7a. Apparently, this 
process is favored over ring closure to form a β-lactam. 
To the best of our knowledge, the C-acylation of a 4,5-dihydro-1,3-thiazole by 
an acid chloride or a ketene has not been reported yet. A reasonable mechanism for the 
reaction 2b→9 is depicted in Scheme 9: the enamine moiety in the tautomeric structure 
2b’ may attack the ketene or acyl chloride to give E, followed by a prototropic 
isomerization. Control experiments showed that the C-acylation is even more favored 
in the absence of Et3N (16% of 7a and 64% of 9). Therefore, an initial deprotonation 
of 2b by the base, to give a benzyl anion, which then could attack the ketene to give E, 
is not necessary.  
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Scheme 9 
 
The formation of 2:1-adducts in reactions of ketenes and 4,5-dihydro-1,3-
thiazoles, i.e., 2-methylene-1,3-oxazin-6-ones or piperidine-2,4-diones, has already 
been reported [10][32]. However, the structure of compound 8 is different from those 
of the above reported bicycles, in which the substituents at C(2) were not involved in 
the formation of the fused ring system. A control experiment showed that 8 was also 
formed via a secondary acylation of the N-acylation product 7a: in refluxing hexane, 
in the presence of 3a and Et3N, 8 was afforded. A likely reaction mechanism is shown 
in Scheme 10. Deprotonation of 7a and subsequent addition to a second ketene 
molecule could form intermediate F, which may undergo a cyclization via 
nucleophilic attack of the enamine moiety onto the C=O group. An alternative reaction 
sequence via C-acylation of 7a to give G, deprotonation of the N-acyl moiety, and 
cyclization is also conceivable.   
 
Scheme 10 
 
The exchange of the OH group by the azido function was successful in 
monocyclic β-lactams 13 (Scheme 6), but it failed in our bicyclic β-lactams 16 
(Scheme 7). The reason could be the stereochemical hindrance around the 6-sulfonate 
substituent in 17; both the fused thiazolidine ring and the 5-phenyl substituent 
contribute to this hindrance. The first contribution was confirmed by the successful 
substitution in 13, and the latter was supported by a report, in which a 5-unsubstituted 
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6-exo-hydroxypenam was converted to the 6-endo-azidopenam under similar 
conditions as ours [33].  
The acid chloride/imine cycloaddition provides a versatile and convenient way 
to produce monocyclic β-lactams in which high yields. By choosing appropriate 
substituents on both the acid chloride and the imine, a stereoselective formation of 
products could be achieved. However, for bicyclic β-lactams, the yields are generally 
poor, especially for the most desired 5-unsubstituted penams. To solve the problem, 
Nagao et al. [16e] introduced the methylseleno-substituent into the 2-position of 4,5-
dihydro-1,3-thiazoles. With this promotive group, the yield of the cycloadditions 
dramatically improved. The methylseleno-group could be removed afterwards by 
selective reduction using Bu3SnH. Concerning the stereochemistry of the products, the 
method afforded exclusively the undesired stereoisomers, namely the trans β-lactams 
with the substituent at C(6) exo oriented. Thus, to get biologically interesting products, 
an epimerization at C(6) is needed. As the exo → endo transformation was reported to 
be successful in bicyclic β-lactams [33], the combination of Nagao's cycloaddition, 
deselenation, and the above transformation would open the way to the synthesis of 
biologically attractive penams.  
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financial support. 
 
Experimental Part 
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1. General. Solvents: CH2Cl2, Et2O, MeCN, hexane and toluene were distilled 
over CaH2 and stored over molecular sieves (4Å), THF was destilled over Na, DMF, 
MeOH, and EtOH (Merck) were dried over molecular sieves (4Å). TLC: Merck TLC 
aluminum sheets, silica gel 60F254. Column chromatography (CC): silica gel Merck 60 
(0.04-0.063 mm). M.p.: Mettler-FP5 apparatus; uncorrected. IR Spectra: Perkin-Elmer 
297 or Perkin-Elmer 781 spectrophotometer; in CHCl3 unless otherwise stated; 
absorptions in cm–1. 1H-NMR Spectra: Bruker AC-300 (300 MHz), Bruker AM-400 
(400 MHz), and Varian EM-390 (90 MHz) spectrometer, in CDCl3 at 300 K unless 
otherwise stated; ´  in ppm refer to TMS (0 ppm) or residual CHCl3 (7.27 ppm) as 
internal standard; coupling constants J in Hz. 13C-NMR Spectra: Varian XL-200 (50.4 
MHz) spectrometer; ´  in ppm refer to CDCl3 as internal standard (77.0 ppm); signal 
multiplicity from DEPT spectra. MS: Varian MAT-711, Varian MAT-112, Finnigan 
MAT-90, Finnigan SSQ-700, or Finningan TSQ-700 mass spectrometers; EI-mode: 
direct injection, 70 eV; CI-mode: with 2-methylpropane or NH3; m/z (rel. %). 
2. Acid Chloride/Imine Cycloaddition. – General Procedure 1 (GP 1). Into a 
soln. of imine (4,5-dihydro-1,3-thiazole 2 or benzalaniline 11; 5 mmol) and Et3N (1.01 
g, 10 mmol) in CH2Cl2 (50 ml) at r.t., a soln. of acid chloride 3 (10 mmol) in CH2Cl2 
(2 ml) was added within 1 h. After stirring for 1 d, 505 mg (5 mmol) of Et3N was 
added in one portion, and additional 3 (5 mmol) was added dropwise within 1 h. The 
mixture was maintained at r.t. for another 2–3 d, and then filtered through a silica gel 
column. The filtrate was washed with 2N HCl, 5% NaHCO3, and brine, subsequently. 
After removal of the solvent i.v., the residue was either chromatographed or 
recrystallized.  
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General Procedure 2 (GP 2). A soln. of imine (2 or 11; 1 mmol) and acid 
chloride 3 (1.2 mmol) in hexane (15 ml) was heated at reflux for 3 h. Then, a soln. of 
Et3N (3 mmol) in hexane (1 ml) was added within 1 h and the mixture maintained at 
reflux for another 3 h. After addition of Et2O (30 ml), the mixture was filtered through 
a short silica gel column, the filtrate concentrated i.v., and the residue 
chromatographed or recrystallized. 
2.1. Formation of Bicyclic β-Lactams. 2.1.1. 6-exo-Acetoxy-2,2-dimethyl-3-
endo-methylsulfanyl-5-phenyl-4-thia-1-azabicyclo[3.2.0]heptan-7-one (6a) and 6-exo-
acetoxy-2,2-dimethyl-3-exo-methylsulfanyl-5-phenyl-4-thia-1-azabicyclo[3.2.0]-
heptan-7-one (6a’). According to GP 1, with 4,5-dihydro-4,4-dimethyl-5-
methylsulfanyl-2-phenyl-1,3-thiazole [9a] (2a; 762 mg, 3.215 mmol), Et3N (1.30 g, 
12.86 mmol), and acetoxyacetyl chloride (3b, 1.754 mg, 12.86 mmol), after CC with 
hexane/Et2O (10:1), 672 mg (62%) of 6a/6a’ were obtained as a 2:1 mixture of 
diastereoisomers. After prep. TLC with hexane/Et2O (4:1, 4× developing), 6a and 6a’ 
were isolated in pure form. 6a: White crystals. M.p. 126–128°. IR: 2985w, 2920w, 
1785s, 1755s, 1450w, 1390w, 1370m, 1275m, 1255w, 1235m, 1180m, 1160w, 1125m, 
1060w, 1025w, 915w, 700m. 1H-NMR: 7.35–7.3 (m, 5 arom. H); 6.02 (s, HC(6)); 4.55 
(s, HC(3)); 2.26 (s, MeS); 1.94 (s, endo-MeC(3)); 1.64 (s, MeCO); 1.29 (s, exo-
MeC(3)). 13C-NMR: 167.9 (s, C(7)); 167.8 (s, MeCO); 136.9 (s, 1 arom. C); 128.1, 
127.8, 126.2 (3d, 5 arom. CH); 84.4 (d, C(6)); 80.5 (s, C(5)); 72.7 (d, C(3)); 70.5 (s, 
C(2)); 27.5, 21.3 (2q, Me2C); 19.5 (q, MeCO); 16.6 (q, MeS). CI-MS: 340 (12), 339 
(20), 338 (100, [M + 1]+), 290 (17), 238 (17). Anal. calc. for C16H19NO3S2 (337.46): C 
56.95, H 5.68, N 4.15, S 19.00; found: C 56.91, H 5.49, N 4.37, S 19.28.  
Suitable crystals for the X-ray crystal-structure determination were grown from 
hexane/Et2O by slow evaporation of the solvent at r.t. 
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6a’: White crystals. M.p. 100.5–101.5°. IR: 2990w, 2920w, 1770s, 1760s, 
1450w, 1390w, 1370m, 1275m, 1250m, 1240m, 1185m, 1120m, 1050w, 1030m, 920w, 
700m. 1H-NMR: 7.35–7.3 (m, 5 arom. H); 5.90 (s, HC(6)); 4.62 (s, HC(3)); 2.28 (s, 
MeS); 1.87 (s, endo-MeC(3)); 1.63 (s, MeCO); 1.10 (s, exo-MeC(3)). 13C-NMR: 168.5 
(s, MeCO); 167.7 (s, C(7)); 137.0 (s, 1 arom. C); 128.2, 127.7, 126.3 (3d, 5 arom. 
CH); 85.3 (d, C(6)); 79.0 (s, C(5)); 70.7 (d, C(3)); 68.9 (s, C(2)); 22.2, 22.0 (2q, 
Me2C); 19.5 (q, MeCO); 17.3 (q, MeS). CI-MS: 340 (11), 339 (19), 338 (100, [M + 
1]+), 304 (19), 290 (16), 280 (16), 278 (10), 238 (35), 234 (26), 188 (7), 178 (7). Anal. 
calc. for C16H19NO3S2 (337.46): C 56.95, H 5.68, N 4.15, S 19.00; found: C 57.11, H 
5.48, N 4.19, S 18.88. 
2.1.2. 2,2-Dimethyl-3-endo/exo-methylsulfanyl-5-phenyl-6-exo-phthalimido-4-
thia-1-azabicyclo[3.2.0]heptan-7-one (6b). According to GP 2, with 2a (119 mg, 0.5 
mmol), phthalimidoacetyl chloride (3c, 134 mg, 0.6 mmol), and Et3N (152 mg, 1.5 
mmol). After prep. TLC with hexane/Et2O (10:1): 31 mg (15%) of 6b as a mixture of 
2 diastereoisomers. White crystals. M.p. 88°. IR: 3030w, 3000w, 2980w, 2930w, 
1790s, 1775s, 1725s, 1385s, 1270m, 1250m, 1110m, 965w, 710w, 700w. 1H-NMR (2 
diastereoisomers, 1:3): 7.65–7.05 (m, 9 arom. H); 5.84, 5.67 (2s, HC(6)); 4.67, 4.60 
(2s, HC(3)); 2.30 (s, MeS); 2.06, 1.99, 1.45, 1.26 (4s, Me2C). 
13C-NMR (2 
diastereoisomers, 1:3): 168.0 (s, C(7)); 167.3 (s, 2 C=O); 137.3, 130.9 (2s, 3 arom. C); 
134.1, 128.00, 127.97, 127.8, 125.5, 123.3 (6d, 9 arom. C); 79.4 (s, C(5)); 73.1, 70.4 
(2d, C(6)); 71.1, 69.6 (2s, C(2)); 69.2, 68.3 (2d, C(3)); 28.3, 22.5, 21.6, 22.3 (4q, 
Me2C); 17.4, 16.8 (2q, MeS). CI-MS: 425 (11, [M + 1]
+), 260 (16), 259 (100), 238 
(21), 145 (5), 72 (5). Anal. calc. for C22H20N2O3S2 (424.54): C 62.24, H 4.75, N 6.60, 
S 15.11; found: C 62.12, H 4.66, N 6.39, S 15.35. 
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2.2. Formation of Monocyclic β-Lactams. 2.2.1. 3-Acetoxy-1,4-diphenyl-2-
azetidinone (12a) [23a,b]. According to GP 1, with 3b (2.048 g, 15 mmol) and 
benzalaniline (11, 0.905 g, 5 mmol), CC with hexane/Et2O (12:1): 1.299 g (92%) of 
12a (2 diastereoisomers). White crystals. M.p. 138–139°. IR: 1765s, 1760s, 1600w, 
1500m, 1390m, 1380m, 1240m, 1145m, 1100w, 700m. 1H-NMR (2 diastereoisomers, 
1:1): 7.45–7.25 (m, 9 arom. H); 7.15–7.05 (m, 1 arom. H); 5.97, 5.41 (2d, J = 4.9 and 
1.7, resp., HC(3)); 5.40, 4.96 (2d, J = 4.9 and 1.7, resp., HC(4)); 2.21, 1.69 (2s, Me). 
13C-NMR (2 diastereoisomers, 1:1): 169.6, 161.7 (2s, 2 C=O); 136.8–117.4 (12 arom. 
C); 82.4, 76.2 (2d, C(3)); 63.6, 61.3 (2d, C(4)); 20.4, 19.7 (2q, Me). CI-MS: 283 (19), 
282 (100, [M + 1]+), 234 (9), 224 (8), 222 (10), 195 (11), 183 (10), 182 (60), 163 (12), 
147 (19), 133 (7), 101 (15), 94 (47), 93 (9). Anal. calc. for C17 H15NO3 (281.32): C 
72.58, H 5.37, N 4.98; found: C 72.55, H 5.15, N 5.17. 
2.2.2. 3,4-trans-1,4-Diphenyl-3-phthalimido-2-azetidinone (12b) [23d,e]. 
According to GP 1, with 3c (3.353 g, 15 mmol) and 11 (0.905 g, 5 mmol), 
recrystallization from Et2O/CH2Cl2/hexane: 1.068 g (58%) of 12b. White crystals. 
M.p. 224–225° ([23d]: 224–230°). IR: 1765m, 1725s, 1600w, 1500m, 1390m, 1150w, 
1105w, 1090w, 970w, 715w, 700w. 1H-NMR (400 MHz): 7.9–7.85 (m, 2 arom. H); 
7.8–7.75 (m, 2 arom. H); 7.4–7.25 (m, 9 arom. H); 7.1–7.05 (m, 1 arom. H); 5.40 (d, J 
= 2.7, HC(3)); 5.30 (d, J = 2.7, HC(4)). 13C-NMR: 166.7 (s, 2 C=O); 162.0 (s, C(2)); 
137.1–117.6 (18 arom. C); 62.7 (d, C(3)); 61.2 (d, C(4)). CI-MS: 387 (16), 386 (100, 
[M + NH4]
+), 369 (25, [M + 1]+), 366 (14). Anal. calc. for C23H16N2O3 (368.40): C 
74.99, H 4.38, N 7.60; found: C 74.78, H 4.66, N 7.63. 
3. Reactions of Acid Chlorides with 4,5-Dihydro-1,3-thiazoles 2b and 2c. – 3.1. 
2-Benzylidene-3-dichloroacetyl-4,4-dimethyl-5-methylsulfanyl-1,3-thiazolidine (7a) 
and 2,3,6,7-Tetrahydro-6,6-dichloro-7-dichloromethyl-7-hydroxy-3,3-dimethyl-2-
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methylsulfanyl-8-phenyl-5H-pyrido[2,1-b][1,3]thiazol-5-one (8). a) According to GP 
1, with 2b (147 mg, 0.586 mmol), Et3N (237 mg, 2.35 mmol), and 3a (348 mg, 2.35 
mmol), CC with hexane/Et2O (10:1): 114 mg (53%) of 7a and 130 mg (47%) of 8 
(mixture of 2 diastereoisomers). 7a: Brown crystals. M.p. 97–99°. IR: 2960s, 2920s, 
2860s, 1700s, 1600w, 1460w, 1375m, 1355m, 1340m, 1255w, 1170w. 1H-NMR: 7.35–
7.3 (m, 5 arom. H); 6.64 (s, PhCH=C); 6.11 (s, Cl2CH); 4.35 (s, HC(5)); 2.21 (s, MeS); 
1.59, 1.47 (2s, Me2C). 
13C-NMR: 163.9 (s, C=O); 136.4 (s, C(2)); 134.7 (s, 1 arom. 
C); 128.6, 127.9, 127.2 (3d, 5 arom. CH); 113.4 (d, PhCH=C); 67.6 (s, C(4)); 65.2 (d, 
Cl2CH); 64.3 (d, C(5)); 24.3, 20.5 (2q, Me2C); 16.0 (q, MeS). CI-MS: 366 (2), 364 (8), 
362 (11, [M + 1]+), 252 (57), 236 (6), 206 (5), 205 (15), 204 (100), 191 (10), 135 (14). 
Anal. calc. for C15H17Cl2NOS2 (362.34): C 49.72, H 4.73, Cl 19.57, N 3.87, S 17.70; 
found: C 50.00, H 5.00, Cl 19.65, N 3.72, S 17.51.  
8: Yellow oil. IR: 3540m, 3020w, 3000m, 2980m, 2920w, 1720s, 1710s, 1630s, 
1510m, 1385s, 1370s, 1360s, 1310m, 1280m, 1250m, 1170m, 1125s, 1040m, 1020m, 
910m, 850m, 810m, 700m, 650m. 1H-NMR (2 diastereoisomers, 1:1): 7.5–7.4 (m, 5 
arom. H); 6.20, 6.18 (2s, Cl2CH); 4.24, 4.21 (2s, HC(2)); 3.22, 3.17 (2s, OH); 2.20, 
2.14 (2s, MeS); 1.81, 1.74, 1.73, 1.55 (4s, Me2C). 
13C-NMR (2 diastereoisomers, 1:1): 
159.5 (s, C=O); 139.9 (s, C(8a)); 135.5, 135.1 (2s, 1 arom. C); 131.4, 131.3, 128.7, 
128.6, 128.56, 128.5 (6d, 5 arom. CH); 128.8, 128.7 (2s, C(8)); 106.3, 105.0 (2s, 
C(7)); 81.8, 81.6 (2s, C(6)); 76.3, 76.2 (2d, Cl2CH); 72.1, 71.8 (2s, C(3)); 62.0, 61.8 
(2d, C(2)); 25.2, 24.3, 21.8, 19.0 (4q, Me2C); 16.5, 14.9 (2q, MeS). CI-MS: 478 (13), 
476 (53), 474 (100), 472 (76, [M + 1]+), 456 (6), 447 (8), 442 (7), 440 (16), 439 (6), 
438 (34), 436 (35), 428 (12), 426 (24), 424 (21), 422 (14), 420 (13), 402 (13), 400 
(27), 398 (20), 396 (15), 364 (8), 362 (6), 354 (6).  
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b) Into a soln. of 7a (66 mg, 0.18 mmol) and Et3N (55 mg, 0.54 mmol) in 
hexane (5 ml), 32 mg (0.22 mmol) of 3a were added dropwise. The mixture was 
heated at reflux for 4 h. After removal of the solvent i.v., the residue was 
chromatographed with hexane/Et2O (10:1), furnishing 26 mg (31%) of 8. 
3.2. (E)-2-(3,3-Dichloro-2-oxo-1-phenylpropylidene)-4,4-dimethyl-5-
(methylthio)-1,3-thiazolidine (9). a) According to GP 2, with 2b (301 mg, 1.2 mmol), 
3a (195 mg, 1.32 mmol), and Et3N (303 mg, 3 mmol), CC with hexane/Et2O (10:1): 
159 mg (37%) of 7a and 195 mg (45%) of 9: White crystals. M.p. 138.5–140°. IR 
(KBr): 2950m, 1600s, 1510s, 1505s, 1380s, 1370s, 1330m, 1260m, 1165m, 1135m, 
980w, 820m, 800m, 770m, 705m, 695m, 650m. 1H-NMR: 10.92 (s, NH); 7.6–7.25 (m, 
5 arom. H); 5.91 (s, Cl2CH); 4.39 (s, HC(5)); 2.17 (s, MeS); 1.57 (s, Me2C). 
13C-
NMR: 179.5 (s, C=O); 170.8 (s, C(2)); 136.2 (s, 1 arom. C); 131.8, 129.0, 128.4 (3d, 5 
arom. CH); 100.4 (s, PhC=C); 69.1 (s, C(4)); 68.0 (d, Cl2CH); 63.2 (d, C(5)); 27.5, 
23.3 (2q, Me2C); 15.5 (q, MeS). CI-MS: 366 (17), 365 (13), 364 (74), 363 (20), 362 
(100, [M + 1]+), 330 (7), 328 (7). Anal. calc. for C15H17Cl2NOS2 (362.34): C 49.72, H 
4.73, Cl 19.57, N 3.87, S 17.70; found: C 49.50, H 4.48, Cl 19.77, N 3.99, S 17.40.  
Suitable crystals for the X-ray crystal-structure determination were grown from 
hexane/Et2O by slow evaporation of the solvent. 
b) Into a soln. of 2b (189 mg, 0.75 mmol) in hexane (10 ml), 3a (167 mg, 1.13 
mmol) was added. The mixture was heated under reflux for 3 h. After addition of Et2O 
(30 ml), the mixture was filtered through a short silica gel column, and the filtrate 
concentrated i.v. After CC with hexane/Et2O (10:1), 43 mg (16%) of 7a and 174 mg 
(64%) of 9 were obtained. 
3.3. (Z)-3-(Acetoxyacetyl)-2-benzylidene-4,4-dimethyl-5-methylsulfanyl-1,3-
thiazolidine (7b). According to GP 2, with 2b (228 mg, 0.908 mmol), 3b (248 mg, 
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1.817 mmol), and Et3N (367 mg, 3.63 mmol), CC with hexane/Et2O (10:1): 112 mg 
(35%) of 7b. White crystals. M.p. 87–88.5°. IR: 3005w, 2920w, 1745s, 1680s, 1610w, 
1490w, 1445w, 1420w, 1385s, 1370m, 1315m, 1240m, 1170m, 1070m, 910m, 695m. 
1H-NMR: 7.4–7.35 (m, 5 arom. H); 6.32 (s, PhCH=C); 4.93 (s, CH2); 4.37 (s, HC(5)); 
2.26 (s, MeCO); 2.17 (s, MeS); 1.68, 1.53 (2s, Me2C). 
13C-NMR: 170.3 (s, MeCO); 
166.5 (s, C=O); 135.7 (s, C(2)); 135.2 (s, 1 arom. C); 128.4, 127.8, 126.8 (3d, 5 arom. 
CH); 114.5 (d, PhCH=C); 67.4 (s, C(4)); 64.5 (d, C(5)); 63.3 (t, CH2); 24.9 (q, 
MeCO); 21.0, 20.4 (2q, Me2C); 16.0 (q, MeS). CI-MS: 354 (12), 353 (21), 352 (100, 
[M + 1]+), 351 (11), 304 (7). Anal. calc. for C17H21NO3S2 (351.49): C 58.09, H 6.02, N 
3.99, S 18.24; found: C 58.22, H 5.91, N 4.02, S 18.03. 
Suitable crystals for the X-ray crystal-structure determination were grown from 
hexane/Et2O by slow evaporation of the solvent. 
3.4. 2-Benzylidene-4,4-dimethyl-5-methylsulfanyl-3-(phthalimidoacetyl)-1,3-
thiazolidine (7c). According to GP 2, with 2b (69 mg, 0.275 mmol), 3c (74 mg, 0.33 
mmol), and Et3N (83 mg, 0.82 mmol), CC with hexane/Et2O (8:1): 30 mg (25%) of 7c. 
Pale yellow powder. M.p. 55–56°. IR (KBr): 2920w, 1770w, 1720s, 1680m, 1610w, 
1420m, 1390m, 1370m, 1290w, 1270w, 1230w, 1110w, 955w, 750w, 715w, 695w. 1H-
NMR: 7.9–7.85 (m, 2 arom. H); 7.75–7.7 (m, 2 arom. H); 7.4–7.25 (m, 5 arom. H); 
6.57 (s, CH=C); 4.84, 4.76 (AB, J = 16.4, CH2); 4.41 (s, HC(5)); 2.29 (s, MeS); 1.68, 
1.52 (2s, Me2C). 
13C-NMR: 167.6, 165.7 (2s, 3 C=O); 135.7 (s, C(2)); 135.2, 131.9 
(2s, 3 arom. C); 133.9, 128.4, 127.9, 126.8, 123.3 (5d, 9 arom. CH); 115.5 (d, CH=C); 
67.7 (s, C(4)); 64.4 (d, C(5)); 41.7 (t, CH2); 24.9, 21.0 (2q, Me2C); 15.9 (q, MeS). CI-
MS: 441 (12), 440 (28), 439 (100, [M + 1+]), 391 (5). Anal. calc. for C23H22N2O3S2 
(438.57): C 62.99, H 5.06, N 6.39, S 14.62; found: C 63.18, H 5.32, N 6.34, S 14.41. 
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3.5. 3-Dichloroacetyl-2-(3,3-dichloro-2-oxopropylidene)-4,4-dimethyl-5-
methylsulfanyl-1,3-thiazolidine (10). According to GP 2, with 4,5-dihydro-2,4,4-
trimethyl-5-methylsulfanyl-1,3-thiazole (2c; 175 mg, 1 mmol), 3a (178 mg, 1.2 
mmol), and Et3N (251 mg, 2.5 mmol), CC with hexane/Et2O (10:1): 53 mg (19%) of 
10. Yellow oil. IR: 3200w, 3000m, 2980m, 2920m, 1725s, 1660m, 1595m, 1530s, 
1515s, 1505s, 1390m, 1370m, 1320s, 1270m, 1160s, 1120m, 810m. 1H-NMR: 6.52 (s, 
CH=C); 6.27, 5.90 (2s, 2 Cl2CH); 4.29 (s, HC(5)); 2.29 (s, MeS); 1.65, 1.59 (2s, 
Me2C). 
13C-NMR: 184.7, 165.7 (2s,  2 C=O); 163.2 (s, C(2)); 96.1 (d, CH=C); 71.6 (s, 
C(4)); 69.5, 64.5 (2d, 2 Cl2CH); 62.1 (d, C(5)); 24.0, 20.4 (2q, Me2C); 15.8 (q, MeS). 
CI-MS: 402 (8), 400 (28), 399 (9), 398 (49), 397 (9), 396 (35, [M + 1]+), 312 (5), 290 
(13), 289 (9), 288 (69), 287 (14), 286 (100), 202 (6). 
4. Hydrolysis of 3-Acetoxy-2-azetidinone 12a and 6-Acetoxypenam 6a. – 4.1. 
trans-3-Hydroxy-1,4-diphenyl-2-azetidinone (trans-13) and cis-3-hydroxy-1,4-
diphenyl-2-azetidinone (cis-13). Into a soln. of 12a (410 mg, 1.46 mmol) in MeOH (50 
ml) at 0°, a soln. of sat. aq. NaHCO3 (2 ml) was added. The mixture was maintained at 
0° for 30 min. Then, AcOEt (200 ml) and H2O  (80 ml) were added. The org. phase 
was separated, and the aq. phase was extracted with AcOEt (3 x 120 ml). The 
combined org. phase was washed with brine, dried (Na2SO4), filtered, and 
concentrated i.v. After CC of the residue with hexane/Et2O (8:1), afforded 153 mg 
(44%) of trans-13 and 151 mg (43%) of cis-12. trans-13 [25b]: White crystals. M.p. 
181–183° ([25b]: 180–181°). IR: 3350w, 1750s, 1600w, 1505m, 1385m, 1140w. 1H-
NMR: 7.4–7.2 (m, 9 arom. H); 7.1–7.05 (m, 1 arom. H); 4.92 (d, J = 1.8, HC(4)); 4.76 
(dd, J = 1.8, 6.2, HC(2)); 3.49 (d, J = 6.2, OH). 13C-NMR ((D5)Py): 168.0 (s, C=O); 
138.3, 137.9 (2s, 2 arom. C);  129.6, 128.8, 126.6, 124.3, 117.9 (5d, 10 arom. CH); 
85.5 (d, C(3)); 66.6 (d, C(4)). CI-MS: 258 (16), 257 (100, [M + NH4]
+), 241 (16), 240 
 23 
(100, [M + 1]+). Anal. calc. for C15H13NO2 (239.28): C 75.30, H 5.48, N 5.85; found: 
C 75.42, H 5.27, N 6.00.  
cis-13 [25b]: White crystals. M.p. 199–201° ([25b]: 206–207°). IR: 3600w, 
3000w, 1750s, 1600w, 1500m, 1455w, 1385m, 1265m, 1150w, 1115m, 700m. 1H-
NMR: 7.45–7.25 (m, 9 arom. H); 7.15–7.05 (m, 1 arom. H); 5.33 (d, J = 5.4, HC(4)); 
5.21 (dd, J = 5.4, 9.2, HC(3)); 2.21 (d, J = 9.2, OH). 13C-NMR ((D5)Py): 168.3 (s, 
C=O); 138.6, 135.7 (2s, 2 arom. C); 129.6, 128.9, 128.6, 128.4, 124.3, 117.8 (6d, 10 
arom. CH); 78.6 (d, C(3)); 63.3 (d, C(4)). CI-MS: 258 (17), 257 (100, [M + NH4]
+), 
241 (5), 240 (30, [M + 1]+), 58(5). Anal. calc. for C15H13NO2 (239.28): C 75.30, H 
5.48, N 5.85; found: C 75.51, H 5.27, N 5.97. 
4.2. 6-exo-Hydroxy-2,2-dimethyl-3-endo-methylsulfanyl-5-phenyl-4-thia-1-
azabicyclo[3.2.0]heptan-7-one (endo-16) and 6-exo-hydroxy-2,2-dimethyl-3-exo-
methylsulfanyl-5-phenyl-4-thia-1-azabicyclo[3.2.0]heptan-7-one (exo-16). In analogy 
to experiment 4.1, the reaction of 6a (460 mg, 1.36 mmol) with sat. NaHCO3 (3 ml) at 
0° for 1 h afforded, after CC with hexane/Et2O (5:1), 307 mg (76%) of 16 as a mixture 
of 2 diastereoisomers. After prep. TLC with hexane/Et2O (4:1), endo- and exo-16 were 
isolated in pure form. endo-16: White crystals. M.p. 103.5–104.5°. IR: 3560m, 3380m, 
3000m, 2980m, 2920m, 1760s, 1600w, 1480w, 1460w, 1445m, 1390m, 1370m, 1280s, 
1210s, 1180s, 1150s, 1060m, 1030m, 1005m, 980m, 870m, 850m, 700s, 640m. 1H-
NMR: 7.45–7.35 (m, 5 arom. H); 5.22 (d, J = 9.6, HC(6)); 4.54 (s, HC(3)); 2.32 (d, J = 
9.6, OH); 2.24 (s, MeS); 1.91, 1.32 (2s, Me2C). 
13C-NMR: 173.3 (s, C=O); 138.1 (s, 1 
arom. C); 128.3, 128.1, 126.2 (3d, 5 arom. CH); 86.9 (d, C(6)); 81.7 (s, C(5)); 72.8 (d, 
C(3)); 69.9 (s, C(2)); 27.8, 21.3 (2q, Me2C); 16.7 (q, MeS). CI-MS: 296 (25, [M + 
1]+), 240 (9), 239 (14), 238 (100). Anal. calc. for C14H17NO2S2 (295.43): C 56.92, H 
5.80, N 4.74, S 21.71; found: C 56.64, H 5.79, N 4.54, S 21.50.  
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exo-16: White crystals. M.p. 141.5–142.7°. IR: 3560w, 3330w, 2980m, 2920w, 
1760s, 1450m, 1390m, 1370m, 1290m, 1260m, 1170m, 1145m, 700m. 1H-NMR: 7.45–
7.35 (m, 5 arom. H); 5.07 (d, J = 9.6, HC(6)); 4.54 (s, HC(3)); 2.27 (s, MeS); 2.14 (d, J 
= 9.6, OH); 1.85, 1.13 (2s, Me2C). 
13C-NMR ((CD3)2CO): 172.2 (s, C=O); 139.8 (s, 1 
arom. C); 128.3, 128.1, 126.9 (3d, 5 arom. CH); 89.6 (d, C(6)); 80.9 (s, C(5)); 70.4 (d, 
C(3)); 68.8 (s, C(2)); 22.4, 22.3 (2q, Me2C); 17.0 (q, MeS). CI-MS: 313 (100, [M +  
NH4]
+), 296 (25, [M + 1]+), 284 (18), 283 (14), 269 (17), 267 (25), 238 (43). 
Suitable crystals of exo-16 for the X-ray crystal-structure determination were 
grown from CH2Cl2/Et2O/hexane by slow evaporation of the solvent. 
5. Sulfonylation of 3-Hydroxy-2-azetidinones 13 and 6-Hydroxypenams 16. – 
5.1. trans-3-{[(4-Chlorophenyl)sulfonyl]oxy}-1,4-diphenyl-2-azetidinone (trans-14). 
Into a soln. of trans-13 (190 mg, 0.795 mmol) in CH2Cl2 at 0°, Hünig’s base (103 mg, 
0.80 mmol) was added. After stirring for 10 min, a soln. of (4-chlorobenzene)sulfonyl 
chloride (252 mg, 1.19 mmol) in CH2Cl2 (2 ml) was added dropwise. The mixture was 
stirred overnight allowing the temp. to rise to r.t. Then, CH2Cl2 (50 ml) was added. 
The org. phase was washed with brine, dried (Na2SO4), filtered, and concentrated i.v. 
Crystallization of the residue (CH2Cl2/Et2O/hexane) furnished 296 mg (90%) of trans-
14. White crystals. M.p. 187.0–187.5°. IR: 1770s, 1600w, 1590w, 1500m, 1385s, 
1190m, 1185m, 1145m, 1090m, 1070m, 870m, 845m, 830m, 700w. 1H-NMR: 7.85–7.8 
(m, 2 arom. H); 7.55–7.5 (m, 2 arom. H); 7.45–7.35 (m, 3 arom. H); 7.3–7.2 (m, 6 
arom. H); 7.15–7.05 (m, 1 arom. H); 5.15 (d, J = 1.6, HC(3)); 5.11 (d, J = 1.6, HC(4)). 
13C-NMR ((D6)DMSO): 159.1 (s, C=O); 140.2, 135.8, 133.9, 133.2 (4s, 4 arom. C); 
130.0, 129.8, 129.1, 128.9, 128.7, 126.9, 124.8, 117.6 (8d, 14 arom. CH); 84.7 (d, 
C(3)); 62.2 (d, C(4)). CI-MS: 433 (30), 432 (27), 431 (100, [M + NH4]
+), 414 (12, [M 
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+ 1]+). Anal. calc. for C21H16ClNO4S (413.88): C 60.94, H 3.90, Cl 8.57, N 3.38, S 
7.75; found: C 61.10, H 4.05, Cl 8.85, N 3.37, S 7.49. 
5.2. cis-3-{[(4-Chlorophenyl)sulfonyl]oxy}-1,4-diphenyl-2-azetidinone (cis-
14). In analogy to experiment 5.1, from cis-13 (160 mg, 0.67 mmol), Hünig’s base 
(203 mg, 2.35 mmol), and (4-chlorobenzene)sulfonyl chloride (495 mg, 2.35 mmol), 
after crystallization from CH2Cl2/Et2O/hexane, 259 mg (94%) of cis-14 were obtained. 
White crystals. M.p. 209–211°. IR: 1765s, 1600w, 1500m, 1385m, 1190m, 1175m, 
1085m, 870m, 830m, 700w. 1H-NMR: 7.5–7.25 (m, 13 arom. H); 7.15–7.05 (m, 1 
arom. H); 5.85 (d, J = 5.0, HC(3)); 5.34 (d, J = 5.0, HC(4)). 13C-NMR ((D6)DMSO): 
160.0 (s, C=O); 139.8, 136.2, 133.6, 131.9 (4s, 4 arom. C); 129.8, 129.2, 129.0, 128.7, 
128.4, 127.8, 124.7, 117.1 (8d, 14 arom. C); 79.8 (d, C(3)); 60.2 (d, C(4)). EI-MS: 413 
(9, M+), 296 (25), 295 (12), 294 (67), 239 (14), 238 (86), 221 (9), 183 (15), 182 (100), 
181 (31), 180 (59), 175 (22), 159 (27), 152 (11), 131 (34). Anal. calc. for 
C21H16ClNO4S (413.88): C 60.94, H 3.90, Cl 8.57, N 3.38, S 7.75; found: C 60.81, H 
3.79, Cl 8.29, N 3.38, S 7.97. 
5.3. 6-exo-{[(4-Chlorophenyl)sulfonyl]oxy}-2,2-dimethyl-3-endo-
methylsulfanyl-5-phenyl-4-thia-1-azabicyclo[3.2.0]heptan-7-one (endo-17a) and 6-
exo-{[(4-chlorophenyl)sulfonyl]oxy}-2,2-dimethyl-3-exo-methylsulfanyl-5-phenyl-4-
thia-1-azabicyclo[3.2.0]heptan-7-one (exo-17a). Into a soln. of the diastereoisomeric 
mixture of 16 (139 mg, 0.47 mmol) in CH2Cl2 (5 ml) at 0°, Et3N (95 mg, 0.94 mmol) 
was added. After 10 min, a soln. of (4-chlorobenzene)sulfonyl chloride (149 mg, 0.705 
mmol) in CH2Cl2 (1 ml) was added dropwise. The mixture was maintained at r.t. 
overnight, then, CH2Cl2 (30 ml) was added. The soln. was washed with brine, dried 
(Na2SO4), filtered, and concentrated i.v. The residue, after purification by CC with 
hexane/Et2O (15:1), afforded 197 mg (90%) of 17 as a 2:1 mixture of 
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diastereoisomers. After prep. TLC, endo-17a and exo-17a were isolated in pure form. 
endo-17a: White crystals. M.p. 122–123°. IR: 1785s, 1590w, 1480w, 1385m, 1270m, 
1190m, 1180m, 1090m, 990w, 890m, 825m, 700m, 650m. 1H-NMR: 7.5–7.3 (m, 9 
arom. H); 5.84 (s, HC(6)); 4.53 (s, HC(3)); 2.26 (s, MeS); 1.89 (s, endo-MeC(2)); 1.20 
(s, exo-MeC(2)). 13C-NMR: 166.4 (s, C=O); 140.7, 136.6, 134.1 (3s, 3 arom. C); 
129.4, 129.0, 128.5, 128.1, 126.4 (5d, 9 arom. CH); 87.4 (d, C(6)); 80.6 (s, C(5)); 72.9 
(d, C(3)); 70.8 (s, C(2)); 27.3, 21.3 (2q, Me2C); 16.7 (q, MeS). CI-MS: 487 (7), 472 
(9), 470 (19, [M + 1]+), 240 (9), 239 (14), 238 (100), 145 (6). Anal. calc. for 
C20H20ClNO4S3 (470.03): C 51.11, H 4.29, N 2.98, S 20.46; found: C 51.40, H 4.10, N 
3.07, S 20.93.  
exo-17a: White crystals. M.p. 131.5–132.7°. IR: 2980m, 2930w, 1785s, 1590m, 
1480m, 1450m, 1400m, 1390m, 1375m, 1275m, 1260m, 1190s, 1180m, 1090s, 1050m, 
1000m, 895m, 825m, 700m, 650m, 625m. 1H-NMR: 7.5–7.25 (m, 9 arom. H); 5.71 (s, 
HC(6)); 4.57 (s, HC(3)); 2.27 (s, MeS); 1.81 (s, endo-MeC(2)); 1.01 (s, exo-MeC(2)). 
13C-NMR: 165.1 (s, C=O); 140.7, 136.1, 134.0 (3s, 3 arom. C); 129.4, 129.0, 128.5, 
127.9, 126.5 (5d, 9 arom. CH); 88.2 (d, C(6)); 79.1 (s, C(5)); 70.9 (d, C(3)); 69.1 (s, 
C(2)); 25.3, 22.1 (2q, Me2C); 17.3 (q, MeS). CI-MS: 491 (6), 490 (10), 489 (48), 488 
(23), 487 (100, [M + NH4]
+), 472 (5), 470 (11, [M + 1]+). 
5.4. 2,2-Dimethyl-3-endo/exo-methylsulfanyl-6-exo-{[(2,4-
dinitrophenyl)sulfonyl]oxy}-5-phenyl-4-thia-1-azabicyclo[3.2.0]heptan-7-one (17b). 
In analogy to experiment 5.3, from 16 (2:1 mixture of 3-endo and 3-exo isomers; 267 
mg, 0.9 mmol), and (2,4-dinitrobenzene)sulfonyl chloride (360 mg, 1.35 mmol), 410 
mg (87%) of 17b were obtained as a 2:1 mixture of diastereoisomers. Pale yellow 
foam. M.p. 55–57°. IR: 3090w, 3030w, 3010w, 2920w, 1785s, 1610w, 1560s, 1545s, 
1450w, 1410m, 1390m, 1375m, 1350s, 1270w, 1190s, 1090m, 1050w, 1000w, 980m, 
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890m, 830m, 700m, 645m, 620m. 1H-NMR (3-endo/3-exo isomers, 2:1): 8.6–8.55 (m, 
1 arom. H); 8.5–8.4 (m, 1 arom. H); 8.15–8.0 (m, 1 arom. H); 7.45–7.15 (m, 5 arom. 
H); 5.98, 5.90 (2s, HC(6)); 4.62, 4.55 (2s, HC(3)); 2.28, 2.27 (2s, MeS); 1.89, 1.82, 
1.23, 1.03 (4s, Me2C). 
13C-NMR: 165.5, 164.2 (2s, C=O); 150.3, 147.8, 147.7, 136.2, 
135.8, 134.6, 134.4 (7s, 4 arom. C); 132.7, 132.6, 128.7, 128.5, 128.2, 127.9, 127.8, 
126.8, 126.4, 126.2, 120.1 (11d, 8 arom. CH); 89.8, 88.9 (2d, C(6)); 80.4, 78.9 (2s, 
C(5)); 72.8, 70.9 (2s, C(2)); 71.0, 69.2, (2d, C(3)); 27.2, 22.0, 21.6, 21.2 (4q, Me2C); 
17.3, 16.6 (2q, MeS). CI-MS: 545 (17), 544 (23), 543 (100, [M + NH4]
+), 527 (5), 526 
(10, [M + 1]+ ), 511 (3). Anal. calc. for C20H19N3O8S3 (525.58): C 45.71, H 3.64, N 
7.99, S 18.30; found: C 45.86, H 3.74, N 8.18, S 18.09. 
6. Substitution Reaction of 3-{[(4-Chlorophenyl)sulfonyl]oxy}-2-azetidinones 
14 with Azides. – 6.1. cis-3-Azido-1,4-diphenyl-2-azetidinone (cis-15) [24b]. A 
mixture of trans-14 (100 mg, 0.24 mmol) and NaN3 (156 mg, 2.4 mmol) in DMF (5 
ml) was heated to 55° for 1 d. Then, AcOEt (30 ml) and brine (10 ml) were added. The 
aq. phase was extracted with AcOEt (3 x 10 ml). The combined org. phase was dried 
(Na2SO4), filtered, and concentrated i.v. The residue, after purification by CC with 
hexane/Et2O (20:1), furnished 53 mg (82%) of cis-15. White crystals. M.p. 130–131° 
([24b]: 132–134°). IR: 2120s, 1760s, 1600w, 1500m, 1385m, 1135m, 700w. 1H-NMR: 
7.35–7.3 (m, 3 arom. H); 7.3–7.2 (m, 6 arom. H); 7.05–7.0 (m, 1 arom. H); 5.26 (d, J = 
5.4, HC(3)); 4.97 (d, J = 5.4, HC(4)). 13C-NMR: 161.4 (s, C=O); 136.0, 132.4 (2s, 2 
arom. C); 129.1, 129.0, 128.8, 127.4, 124.7, 117.4 (6d, 10 arom. CH); 67.3 (d, C(3)); 
60.6 (d, C(4)). CI-MS: 283 (14), 282 (100, [M + NH4]
+), 265 (3, [M + 1]+), 254 (31), 
237 (12). Anal. calc. for C15H12N4O (264.29): C 68.17, H 4.58, N 21.20; found: C 
68.26, H 4.38, N 20.93. 
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6.2. trans-3-Azido-1,4-diphenyl-2-azetidinone (trans-15). a) In analogy to 
experiment 6.1, from cis-14 (166 mg, 0.4 mmol), and NaN3 (260 mg, 4 mmol), 92 mg 
(87%) of trans-15 were obtained. Colorless oil ([24b]: m.p. 81–83°). IR: 3060w, 
3030w, 3005w, 2920w, 2115s, 1760s, 1600s, 1500s, 1490s, 1455m, 1380s, 1355m, 
1330m, 1320m, 1300m, 1280m, 1260m, 1145s, 1105w, 1090w, 1080w, 1030w, 990w, 
900w, 850m, 700s, 690s, 630w, 605m. 1H-NMR: 7.45–7.25 (m, 9 arom. H); 7.15–7.05 
(m, 1 arom. H); 4.88 (d, J = 2.1, HC(3)); 4.52 (d, J = 2.1, HC(4)). 13C-NMR: 161.3 (s, 
C=O); 136.6, 135.2 (2s, 2 arom. C); 129.3, 129.2, 129.1, 125.9, 124.6, 117.4 (6d, 10 
arom. CH); 72.3 (d, C(3)); 62.8 (d, C(4)). CI-MS: 299 (100, [M + 1 + 2 NH3]
+), 282 
(73, [M + NH4]
+), 271 (39), 265 (2, [M + 1]+), 254 (27), 237 (8). Anal. calc. for 
C15H12N4O (264.29): C 68.17, H 4.58, N 21.20; found: C 68.18, H 4.67, N 20.95. 
b) In analogy to experiment 6.1, from cis-14 (83 mg, 0.2 mmol), and LiN3 (98 mg, 
2 mmol), 52 mg (98%) of trans-15 were obtained. 
7. Attempted Substitution Reactions of 6-[(Arylsulfonyl)oxy]-2,2-dimethyl-3-
methylsulfanyl-5-phenyl-4-thia-1-azabicyclo[3.2.0]heptan-7-ones (17). In analogy to 
the reaction described in Chapter 6, the mixture of diastereoisomers 17a (ca. 0.3 
mmol) and NaN3 (ca. 3 mmol) in DMF (5 ml) was heated to 50–60°C. After usual 
workup, only starting material was recovered. Under similar conditions, reactions with 
17b and 17c were also not successful and, in addition to starting material, significant 
amounts of 4,5-dihydro-4,4-dimethyl-5-methylsulfanyl-2-phenyl-1,3-thiazol (2a) were 
isolated. 
8. X-Ray Crystal Structure Determinations of endo-6a, 7b, 9, and exo-16 (see 
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Table and Figs. 1 – 3)6). The measurements for compounds endo-6a, 7b, and 9 were 
made on a Nicolet R3 diffractometer, those for compound exo-16 on a Rigaku AFC5R 
diffractometer and a 12kW rotating anode generator, using graphite-monochromated 
MoK± radiation (» = 0.71073 Å). The intensities were corrected for Lorentz and 
polarization effects, but not for absorption. In all cases, equivalent reflections were 
merged. Data collection and refinement parameters are given in the Table. The 
structures were solved by direct methods using SHELXS86 [34], which revealed the 
positions of all non-H atoms. The non-H atoms were refined anisotropically.  In the 
cases of 9 and exo-16, the H-atom of the NH and OH group, respectively, were placed 
in the positions indicated by a difference electron density map, and their positions 
were allowed to refine together with an isotropic displacement parameter. All other H-
atoms in all structures were placed in geometrically calculated positions and refined by 
using a riding model where each H-atom was assigned a fixed isotropic displacement 
parameter with a value equal to 1.2 Ueq of its parent atom (1.5 Ueq for the Me groups). 
The refinement of each structure was carried out on F2 using full-matrix least-squares 
procedures, which minimized the function Σw(Fo2 – Fc2)2. A correction for secondary 
extinction was not applied. One reflection, whose intensity was considered to be an 
extreme outlier, was omitted from the final refinement of the structure of endo-6a. 
Neutral atom scattering factors for non-H-atoms were taken from [35a], and 
the scattering factors for H-atoms were taken from [36]. Anomalous dispersion effects 
were included in Fc [37]; the values for f' and f" were those of [35b]. The values of the 
mass attenuation coefficients are those of [35c]. All calculations were performed using 
                                                 
6)   CCDC-933805 – 933808 contain the supplementary crystallographic data for this 
paper. These data can be obtained free of charge from The Cambridge 
Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif. 
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the SHELXL97 [38] program.  
 
Table 6. Crystallographic Data for Compounds endo-6a, 7b, 9, and exo-16  
 
 
 31 
REFERENCES 
 
[1] J. Shi, A. Linden, H. Heimgartner, 55th Annual Meeting of the Polish 
Chemical Society, Bialystok, 2012, Abstracts, S06_K06, p. 227. 
[2] a) D. Obrecht, H. Heimgartner, Chimia 1982, 36, 78; b) C. Jenny, H. 
Heimgartner, Helv. Chim. Acta 1986, 69, 374; c) P. Wipf, C. Jenny, H. 
Heimgartner, Helv. Chim. Acta 1987, 70, 1001; d) J. Shi, A. Linden, H. 
Heimgartner, Helv. Chim. Acta 1994, 77, 1903. 
[3] A. Gebert, H. Heimgartner, Helv. Chim. Acta 2002, 85, 2073. 
[4] H. Heimgartner, Croatica Chem. Acta 1986, 59, 237; H. Heimgartner, 
Phosphorus, Sulfur and Silicon 1991, 58, 281. 
[5] a) D. Obrecht, R. Prewo, J. H. Bieri, H. Heimgartner, Helv. Chim. Acta 1982, 
65, 1825; b) T. Büchel, R. Prewo, J. H. Bieri, H. Heimgartner, Helv. Chim. 
Acta 1984, 67, 534; c) S. Pekcan, H. Heimgartner, Helv. Chim. Acta 1988, 71, 
1673; d) G. MlostoD, A. Linden, H. Heimgartner, Helv. Chim. Acta 1991, 74, 
1386; e) G. MlostoD, H. Heimgartner, Helv. Chim. Acta 1992, 75, 1825; f) M. 
Kägi, A. Linden, G. MlostoD, H. Heimgartner, Helv. Chim. Acta 1993, 76, 
1715; g) G. MlostoD, M. Petit, A. Linden, H. Heimgartner, Helv. Chim. Acta 
1994, 77, 435; h) M. Petit, A. Linden, G. MlostoD, H. Heimgartner, Helv. 
Chim. Acta 1994, 77, 1076; i) M. Kägi, G. MlostoD, A. Linden, H. 
Heimgartner, Helv. Chim. Acta 1994, 77, 1299; j) G. MlostoD, A. Linden, H. 
Heimgartner, Polish J. Chem. 1997, 71, 32; k) K.-R. Meier, A. Linden, G. 
MlostoD, H. Heimgartner, Helv. Chim. Acta 1997, 80, 1190; l) G. MlostoD, A. 
Linden, H. Heimgartner, Helv. Chim. Acta 1998, 81, 558. 
[6] P. Tromm, H. Heimgartner, Helv. Chim. Acta 1988, 71, 2071. 
 32 
[7] C. Jenny, H. Heimgartner, Helv. Chim. Acta 1986, 69, 174. 
[8] M. Blagoev, A. Linden, H. Heimgartner, Helv. Chim. Acta 1999, 82, 1458. 
[9] a) C. Jenny, H. Heimgartner, Helv. Chim. Acta 1986, 69, 773; b) C. Jenny, P. 
Wipf, H. Heimgartner, Helv. Chim. Acta 1986, 69, 1837; c) J. Shi, H. 
Heimgartner, Helv. Chim. Acta 1996, 79, 371. 
[10] C. Jenny, R. Prewo, J. H. Bieri, H. Heimgartner, Helv. Chim. Acta 1986, 69, 
1424. 
[11] D. J. Wolter, P. D. Lister, Curr. Pharm. Design 2013, 19, 209; M. Z. 
Hoermann, in ‘Bioactive Heterocyclic Compound Classes’, Eds. J. Dinges, C. 
Lamberth, Wiley-VCH, Weinheim, 2012, p. 237. 
[12] a) I. Banik, B. K. Banik, Topics Heterocycl. Chem. 2013, 30, 183; b) A. L. 
Shaikh, B. K. Banik, Helv. Chim. Acta 2012, 95, 839; c) M. T. Aranda, P. 
Perez-Faginas, R. Gonzales-Muniz, Curr. Org. Synth. 2009, 6, 325; d) D. A. 
Evans, F. Kleinbeck, M. Rueping, in ‘Asymmetric Synthesis’, 2nd ed., Eds. M. 
Christmann, S. Bräse, Wiley-VCH, Weinheim, 2008, p. 77; e) R. Pal, S. C. 
Gosh, K. Chandra, A. Basak, Synlett 2007, 2321; f) J. H. Rigby, J.-C. Brouet, 
P. J. Burke, S. Rohach, S. Sidique, M. J. Heeg, Org. Lett. 2006, 8, 3121. 
[13] H. Staudinger, Liebigs Ann. Chem. 1907, 356, 51. 
[14] A. K. Mukerjee, R. C. Srivastava, Synthesis 1973, 327; R. D. G. Cooper, B. W. 
Daugherty, D. B. Boyd, Pure Appl. Chem. 1987,  59, 485; R. C. Thomas, in 
'Recent Progress in the Chemical Synthesis of Antibiotics', Eds. G. Lukacs, M. 
Ohno, Springer Verlag, Berlin, 1990, p. 533; J. Bateson, in 'Progress in 
Heterocyclic Chemistry', Eds. H. Suschitzky, E. F. V. Scriven, Pergamon 
Press, Oxford, 1991, Vol. 3, Chapter 1, p. 1; F. H. van der Steen, G. van Koten, 
Tetrahedron 1991, 47, 7503; W. Duczek, K. Jähnisch, A. Kunath, G. Reck, G. 
 33 
Winter, B. Schulz, Liebigs Ann. Chem. 1992, 781; V. Srirajan, V. G. Puranik, 
A. R. A. S. Deshmukh, B. M. Bhawal, Tetrahedron 1996, 52, 5579; V. 
Srirajan, A. R. A. S. Deshmukh, B. M. Bhawal, Tetrahedron 1996, 52, 5585; 
C. Palomo, J. M. Aizpurua, I. Ganboa, M. Oiarbide, Eur. J. Org. Chem. 1999, 
3223; M. R. Linder, J. Podleck, Org. Lett. 2001, 3, 1849; B. L. Hodous, G. C. 
Fu, J. Am. Chem. Soc. 2002, 124, 1578; A. E. Taggi, A. M. Hafez, H. Wack, B. 
Yung, D. Ferraris, T. Lectka, J. Am. Chem. Soc. 2002, 124, 6626; E. C. Lee, B. 
L. Hodous, E. Bergin, C. Shih, G. C. Fu, J. Am. Chem. Soc. 2005, 127, 11586; 
A.-R. Zhang, L. He, X. Wu, P.-L. Shao, S. Ye, Org. Lett. 2008, 10, 277; M. 
Zarei, A. Jarrahpour, Synlett 2011, 2572; G. S. Singh, M. D’hooghe, N. De 
Kimpe, Tetrahedron 2011, 67, 1989. 
[15] R. A. Firestone, N. S. Maciejewicz, R. W. Ratcliffe, B. G. Christensen, J. Org. 
Chem. 1974, 39, 437; H. Vanderhaeghe, J. Thomis, J. Med. Chem. 1975, 18, 
486. 
[16] a) R. Pfleger, A. Jager, Chem. Ber. 1957, 90, 2460; b) A. K. Bose, B. 
Anjaneyulu, Chem. Ind. 1966, 903; c) A. K. Bose, G. Spiegelman, M. S. 
Manhas, J. Chem. Soc. (C) 1971, 2468; d) M. S. Manhas, J. S. Chib, A. K. 
Bose, J. Org. Chem. 1973, 38, 1238; e) Y. Nagao, T. Kumigai, S. Takao, T. 
Abe, M. Ochiai, Y. Inoue, T. Taga, E. Fujita, J. Org. Chem. 1986, 51, 4737; f) 
H. Emtenäs, G. Soto, S. J. Hultgren, G. R. Marshall, F. Almqvist, Org. Lett. 
2000, 2, 2065; g) H. Emtenäs, M. Carlsson, J. S. Pinkner, S. J. Hultgren, F. 
Almqvist, Org. Biomol. Chem. 2003, 1, 1308. 
[17] A. G. M. Barrett, J. Mortier, M. Sabat, M. A. Sturgess, Organometalics 1988, 
7, 2553; P. Bissolino, M. Alpegiani, D. Borghi, E. Perrone, G. Franceschi, 
Heterocycles 1993, 36, 1529; D. B. Boggian, E. G. Mata, Synthesis 2006, 
 34 
3397; I. Potorocina, M. Vorona, I. Shestakova, I. Domracheva, E. Liepinsch, 
G. Veinberg, Chem. Heterocycl. Comp. 2011, 7, 767; M. Feroci, Int. J. Org. 
Chem. 2011, 1, 191. 
[18] D. R. Garud, H. Ando, Y. Kawai, H. Ishihara, M. Koketsu, Org. Lett. 2007, 9, 
4455. 
[19] A. Favre, J. Grugier, A. Brans, B. Joris, J. Marchand-Brynaert, Tetrahedron 
2012, 68, 10818. 
[20] S. D. Sharma, U. Mehra, J. Sci. Ind. Res. 1988, 47, 451. 
[21] C. K. Johnson, ‘ORTEP II’, Report ORNL-5138, Oak Ridge National 
Laboratory, Oak Ridge, Tennessee, 1976. 
[22] J. Bernstein, R. E. Davis, L. Shimoni, N.-L. Chang, Angew. Chem. Int. Ed. 
Engl. 1995, 34, 1555. 
[23] a) O. M. Walsh, M. J. Meegan, R. M. Prendergast, T. Al Nakib, Eur. J. Med. 
Chem. 1996, 31, 989; b) B. K. Banik, F. F. Becker, Tetrahedron Lett. 2000, 41, 
6551; c) B. K. Banik, I. Banik, C. Aguilar, M. Medina, Chem. Indian J.  2006, 
3, 76; d) H. D. Ambrosi, A. Kunath, K. Jähnisch, Arch. Pharm. (Weinheim) 
1993, 326, 319; e) D. Bandyopadhyay, J. Cruz, B. K. Banik, Tetrahedron 2012, 
68, 10686. 
[24] a) H. B. Kagan, J. J. Basselier, J. L. Luche, Tetrahedron Lett. 1964, 941; b) A. 
K. Bose, B. Anjaneyulu, S. K. Bhattacharya, M. S. Manhas, Tetrahedron 1967, 
23, 4769; c) J. L. Luche, H. K. Kagan, R. Parthasarathy, G. Tsoucaris, C. De 
Rango, C. Zelwer, Tetrahedron 1967, 23, 1275. 
[25] a) R. Lattrell, G. Lohaus, Liebigs Ann. Chem. 1974, 901; b) M. S. Manhas, H. 
P. S. Chawla, S. G. Amin, A. K. Bose, Synthesis 1977, 407; c) G. Moyna, H. J. 
Williams, A. I. Scott, Synth. Commun. 1997, 27, 1561; d) E. Turos, C. Coates, 
 35 
J.-Y. Shim, Y. Wang, J. M. Leslie, T. E. Long, G. S. Kumar Reddy, A. Ortiz, 
M. Culbreth, S. Dickey, D. V. Lim, E. Alonso, J. Gonzales, Bioorg. Med. 
Chem. 2005, 13, 6289. 
[26] a) M. S. Manhas, S. G. Amin, H. P. S. Chawla, A. K. Bose, J. Heterocycl. 
Chem. 1978, 15, 601; b) F. P. Cossio, C. Palomo, Tetrahedron Lett. 1985, 26, 
4239; c) F. P. Cossio, C. Lopez, M. Oiarbide, C. Palomo, Tetrahedron Lett. 
1988, 29, 3133. 
[27] Y. Wang, Y. Liang, L. Jiao, D.-M. Du, J. Xu, J. Org. Chem. 2006, 71, 6983. 
[28] N. Fu, T. T. Tidwell, Tetrahedron 2008, 64, 10465; A. Macias, E. Alonso, C. 
Del Pozo, A. Venturini, J. Gonzales, J. Org. Chem. 2004, 69, 7004; A. Arrieta, 
F. P. Cossio, B. Lecea, J. Org. Chem. 2000, 65, 8458; F. P. Cossio, J. M. 
Ugalde, X. Lopez, B. Lecea, C. Palomo, J. Am. Chem. Soc. 1993, 115, 995; J. 
E. Lynch, S. M. Riseman, W. L. Laswell, D. M. Tschaen, R. P. Volante, G. B. 
Smith, I. Shinkai, J. Org. Chem. 1989, 54, 3792. 
[29] A. Arrieta, B. Lecea, F. P. Cossio, Topics Heterocycl. Chem. 2010, 22, 313; F. 
P. Cossio, A. Arrieta, M. A. Sierra, Acc. Chem. Res. 2008, 41, 925; A. 
Venturini, J. Gonzales, Mini-Rev. Org. Chem. 2006, 3, 185. 
[30] A. K. Bose, G. Spiegelman, M. S. Manhas, J. Am. Chem. Soc. 1968, 90, 4506. 
[31]  A. K. Bose, J. L. Fahey, J. Org. Chem. 1974, 39, 115. 
[32] R. D. Kimbrough, J. Org. Chem. 1964, 29, 1242; J. C. Martin, V. A. Hoyle, Jr., 
K. C. Brannock, Tetrahedron Lett. 1965, 3589; J. C. Martin, K. C. Brannock, 
R. D. Burpitt, P. G. Gott, V. A. Hoyle, Jr., J. Org. Chem. 1971, 36, 2211; R. N. 
Pratt, G. A. Taylor, S. A. Proctor, J. Chem. Soc. (C) 1967, 1569; A. Medici, G. 
Fantin, M. Fogagnolo, P. Pedrini, A. Dondoni, G. D. Andreetti, J. Org. Chem. 
1984, 49, 590. 
 36 
[33] A. G. M. Barrett, Chem. Soc. Rev. 1991, 20, 95. 
[34] G. M. Sheldrick, SHELXS86, Acta Crystallogr., Sect. A 1990, 46, 467. 
[35] a) E. N. Maslen, A. G. Fox, M. A. O'Keefe, in ‘International Tables for 
Crystallography’, Ed. A. J. C. Wilson, Kluwer Academic Publishers, 
Dordrecht, 1992 Vol. C, Table 6.1.1.1, p. 477; b) D. C. Creagh, W. J. 
McAuley, in ‘International Tables for Crystallography’, Ed. A. J. C. Wilson, 
Kluwer Academic Publishers, Dordrecht, 1992 Vol. C, Table 4.2.6.8, p. 219; c) 
D. C. Creagh, J. H. Hubbell, in ‘International Tables for Crystallography’, Ed. 
A. J. C. Wilson, Kluwer Academic Publishers, Dordrecht, 1992 Vol. C, Table 
4.2.4.3, p. 200. 
[36] R. F. Stewart, E. R. Davidson, W. T. Simpson, J. Chem. Phys. 1965, 42, 3175. 
[37] J. A. Ibers, W. C. Hamilton, Acta Crystallogr. 1964, 17, 781. 
[38] G. M. Sheldrick, SHELXL97, Acta Crystallogr., Sect. A 2008, 64, 112. 
 
 37 
Legends 
 
Fig. 1. ORTEP Plot [21] of the molecular structure of endo-6a (with 30% probability 
ellipsoids; arbitrary numbering of atoms) 
 
Fig. 2. ORTEP Plots [21] of the molecular structures of a) 9 and b) 7b (with 50% 
probability ellipsoids; arbitrary numbering of atoms) 
 
Fig. 3. ORTEP Plot [21] of the molecular structure of exo-16 (with 50% probability 
ellipsoids; arbitrary numbering of atoms) 
 
Table.  Crystallographic Data for Compounds endo-6a, 7b, 9, and exo-16 
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Table.  Crystallographic Data for Compounds endo-6a, 7b, 9, and exo-16 
__________________________________________________________________________________ 
 
  endo-6a 7b 
__________________________________________________________________________________ 
 
Crystallized from hexane/Et2O hexane/Et2O 
Empirical formula C16H19NO3S2 C17H21NO3S2  
Formula weight 337.45  351.48  
Crystal color, habit colorless, prism colorless, prism 
Crystal dimensions [mm] 0.19 × 0.43 × 0.44 0.26 × 0.37 × 0.42 
Temperature [K] 297(1) 213(1) 
Crystal system monoclinic monoclinic 
Space group P21/n P21/n 
Z 4 4 
Reflections for cell determination 25 25 
2θ range for cell determination [°] 30–36 30–34 
Unit cell parameters a [Å] 10.426(4) 5.9871(12) 
 b [Å] 11.718(2) 18.954(4) 
 c [Å] 13.928(2) 16.040(2) 
 β [°] 98.50(2) 98.733(15) 
 V [Å3] 1682(1) 1799.2(6) 
Dx [g cm
–3] 1.332 1.297 
µ(MoKα) [mm–1] 0.327  0.309 
Scan type ω ω 
2θ(max) [°] 55 55 
Total reflections measured 5146 4930 
Symmetry independent reflections 3858 4126 
Reflections with I>2σ(I) 2600 3098 
Reflections used in refinement 3857 4126 
Parameters refined 203 212 
Final R(F)  [I>2σ (I) reflections] 0.0476 0.0460 
 wR(F2)  (all data) 0.1201 0.1085 
Weighting parameters [a; b]a) 0.0499; 0.4814 0.0190; 1.2021 
Goodness of fit 1.020 1.016 
Final ∆max/σ 0.001 0.001 
∆ρ(max; min) [e Å–3] 0.31; –0.20 0.62; –0.31 
______________________________________________________________________ 
a) w–1 = σ 2(Fo2) + (aP)2 + bP  where P = (Fo2 + 2Fc2)/3 
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Table.  Crystallographic Data for Compounds 6a, 7b, 9, and exo-16 (continued) 
__________________________________________________________________________________ 
 
  9 exo-16 
__________________________________________________________________________________ 
 
Crystallized from hexane/Et2O CH2Cl2 /Et2O/hexane 
Empirical formula C15H17Cl2NOS2 C14H17NO2S2  
Formula weight 362.33  295.41  
Crystal color, habit colorless, prism colorless, prism 
Crystal dimensions [mm] 0.16 × 0.40 × 0.46 0.30 × 0.32 × 0.40 
Temperature [K] 213(1) 173(1) 
Crystal system orthorhombic orthorhombic 
Space group Pbca Pbcn 
Z 8 8 
Reflections for cell determination 25 24 
2θ range for cell determination [°] 28–32 15–22 
Unit cell parameters a [Å] 13.6699(15) 10.047(3) 
 b [Å] 13.0980(15) 11.423(3) 
 c [Å] 18.965(2) 24.770(4) 
 β [°] 90 90 
 V [Å3] 3395.7(1) 2842(1) 
Dx [g cm
–3] 1.417 1.380 
µ(MoKα) [mm–1] 0.626  0.371 
Scan type ω ω 
2θ(max) [°] 55 60 
Total reflections measured 4993 5362 
Symmetry independent reflections 3907 4178 
Reflections with I>2σ(I) 2472 3323 
Reflections used in refinement 3907 4178 
Parameters refined 197 179 
Final R(F)  [I>2σ (I) reflections] 0.0541 0.0348 
 wR(F2)  (all data) 0.1263 0.0983 
Weighting parameters [a; b]a) 0.0419; 4.0593 0.0477; 0.6891 
Goodness of fit 1.006 1.038 
Final ∆max/σ 0.001 0.001 
∆ρ(max; min) [e Å–3] 0.57; –0.28 0.43; –0.19 
______________________________________________________________________ 
a) w–1 = σ 2(Fo2) + (aP)2 + bP  where P = (Fo2 + 2Fc2)/3 
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Scheme 1  
 
 
 
Scheme 2  
 
 
Scheme 3 
 
 
 
Scheme 4 
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Scheme 5 
 
 
Scheme 6 
 
 
Scheme 7 
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Scheme 8 
 
 
 
Scheme 9 
  
 
Scheme 10 
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Figure 1 
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Figure 2 
a) b) 
 
         
 
 
 
Figure 3 
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